Podcast: Seralini’s infamous rat study 10 years later — Looking back at the retracted research linking GM corn and glyphosate to cancer

Ten years ago the biotech world froze and horrific images of three tumor-ridden rats penetrated the media. Social media erupted with messages of fear, and anti-biotech activists celebrated the scientific publication that conclusively linked biotech crops and an associated herbicide to cancer and early death. But at the same time a scientific community noted the shortcomings of the work. Eventually the paper was retracted, and independent research commissioned by the European Union failed to replicate the results. Still 10 years later, the three iconic rodents are used to dissuade the public from accepting biotechnology, and push a false narrative that was codified with the Seralini study.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

journal set to retract seralini gm rat cancer study

This week’s podcast features the views of scientists and journalists, including Dr. Mary Mangan, Dr. Alison Van Eenennaam, Jon Entine, Joan Conrow, Michael Robin, Dr. Stuart Smyth, Dr. Myles Power and others.

The opinions expressed are those of the individual guests and not necessarily those of Kevin Folta, Colabra, or the University of Florida.

See the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.